Jeffrey S. Hyams

1. Induction and Maintenance Infliximab Therapy for the Treatment of Moderate-to-Severe Crohn’s Disease in Children
   2006/12/04 by Jeffrey Hyams, Jeffrey S. Hyams, Wallace Crandall +19 · 26 citations
   Biochemistry, Genetics and Molecular Biology · Medicine · #Inflammatory Bowel Disease #Rheumatoid Arthritis Research and Therapies #Celiac Disease Research and Management
2. Safety and Efficacy of Adalimumab for Moderate to Severe Crohn's Disease in Children
   2012/05/02 by Jeffrey S. Hyams, Anne Griffiths, Anne M. Griffiths +14 · 25 citations
   Biochemistry, Genetics and Molecular Biology · Medicine · #Inflammatory Bowel Disease #Rheumatoid Arthritis Research and Therapies #Pregnancy and Medication Impact
3. Consensus for Managing Acute Severe Ulcerative Colitis in Children: A Systematic Review and Joint Statement From ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN
   2011/01/11 by Dan Turner, Simon Travis, Simon P L Travis +28 · 25 citations
   Biochemistry, Genetics and Molecular Biology · Nursing · #Inflammatory Bowel Disease #Clinical Nutrition and Gastroenterology #Infant Nutrition and Health
4. Real‐World Infliximab Pharmacokinetic Study Informs an Electronic Health Record‐Embedded Dashboard to Guide Precision Dosing in Children with Crohn’s Disease
   2020/12/24 by Ye Xiong, Tomoyuki Mizuno, Ruben J. Colman +13 · 25 citations
   Biochemistry, Genetics and Molecular Biology · Medicine · #Inflammatory Bowel Disease #Microscopic Colitis #Pregnancy and Medication Impact